278 related articles for article (PubMed ID: 33549532)
1. Structural and functional remodeling of mitochondria as an adaptive response to energy deprivation.
Kuznetsov AV; Javadov S; Margreiter R; Grimm M; Hagenbuchner J; Ausserlechner MJ
Biochim Biophys Acta Bioenerg; 2021 Jun; 1862(6):148393. PubMed ID: 33549532
[TBL] [Abstract][Full Text] [Related]
2. 2-Deoxy-D-glucose has distinct and cell line-specific effects on the survival of different cancer cells upon antitumor drug treatment.
Maximchik P; Abdrakhmanov A; Inozemtseva E; Tyurin-Kuzmin PA; Zhivotovsky B; Gogvadze V
FEBS J; 2018 Dec; 285(24):4590-4601. PubMed ID: 30375744
[TBL] [Abstract][Full Text] [Related]
3. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors.
Wanyan Y; Xu X; Liu K; Zhang H; Zhen J; Zhang R; Wen J; Liu P; Chen Y
Molecules; 2020 Dec; 25(23):. PubMed ID: 33297583
[TBL] [Abstract][Full Text] [Related]
4. 2-deoxy-D-glucose augments photodynamic therapy induced mitochondrial caspase-independent apoptosis and energy-mediated autophagy.
Feng X; Shi Y; Xie L; Zhang K; Wang X; Liu Q; Wang P
Lasers Surg Med; 2019 Apr; 51(4):352-362. PubMed ID: 30277589
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation.
Boyle KA; Van Wickle J; Hill RB; Marchese A; Kalyanaraman B; Dwinell MB
J Biol Chem; 2018 Sep; 293(38):14891-14904. PubMed ID: 30087121
[TBL] [Abstract][Full Text] [Related]
6. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
Wu Y; Sarkissyan M; Mcghee E; Lee S; Vadgama JV
Breast Cancer Res Treat; 2015 Jun; 151(3):529-39. PubMed ID: 25975952
[TBL] [Abstract][Full Text] [Related]
7. Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation.
Cheng G; Zielonka J; McAllister D; Tsai S; Dwinell MB; Kalyanaraman B
Br J Cancer; 2014 Jul; 111(1):85-93. PubMed ID: 24867695
[TBL] [Abstract][Full Text] [Related]
8. Berberine combined with 2-deoxy-d-glucose synergistically enhances cancer cell proliferation inhibition via energy depletion and unfolded protein response disruption.
Fan LX; Liu CM; Gao AH; Zhou YB; Li J
Biochim Biophys Acta; 2013 Nov; 1830(11):5175-83. PubMed ID: 23872355
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
10. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
[TBL] [Abstract][Full Text] [Related]
11. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
[TBL] [Abstract][Full Text] [Related]
12. 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
Ihrlund LS; Hernlund E; Khan O; Shoshan MC
Mol Oncol; 2008 Jun; 2(1):94-101. PubMed ID: 19383331
[TBL] [Abstract][Full Text] [Related]
13. Modulation of mitochondrial morphology by bioenergetics defects in primary human fibroblasts.
Guillery O; Malka F; Frachon P; Milea D; Rojo M; Lombès A
Neuromuscul Disord; 2008 Apr; 18(4):319-30. PubMed ID: 18395446
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects of 2-deoxy-d-glucose on interictal- and ictal-like activity when K
Nedergaard S; Andreasen M
J Neurophysiol; 2018 May; 119(5):1912-1923. PubMed ID: 29412775
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition.
Kosic M; Arsikin-Csordas K; Paunovic V; Firestone RA; Ristic B; Mircic A; Petricevic S; Bosnjak M; Zogovic N; Mandic M; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
J Biol Chem; 2016 Oct; 291(44):22936-22948. PubMed ID: 27587392
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells.
Blanquer-Rosselló MD; Hernández-López R; Roca P; Oliver J; Valle A
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):431-440. PubMed ID: 27760368
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dynamics and motility inside living vascular endothelial cells: role of bioenergetics.
Giedt RJ; Pfeiffer DR; Matzavinos A; Kao CY; Alevriadou BR
Ann Biomed Eng; 2012 Sep; 40(9):1903-16. PubMed ID: 22527011
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.
Li J; Huang Q; Long X; Guo X; Sun X; Jin X; Li Z; Ren T; Yuan P; Huang X; Zhang H; Xing J
Oncogene; 2017 Aug; 36(34):4901-4912. PubMed ID: 28436948
[TBL] [Abstract][Full Text] [Related]
19. Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.
Issaq SH; Teicher BA; Monks A
Cell Cycle; 2014; 13(7):1152-61. PubMed ID: 24553119
[TBL] [Abstract][Full Text] [Related]
20. Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells.
Xiao H; Li S; Zhang D; Liu T; Yu M; Wang F
Oncol Rep; 2013 Jan; 29(1):329-34. PubMed ID: 23076497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
